Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colonic Polyps 2Breast Neoplasms 2Rectal Diseases 1Prostatic Neoplasms 1Pneumoperitoneum 1Pancreatic Neoplasms 1Pain, Postoperative 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Gastric Subepithelial Tumor 1Erectile Dysfunction 1Endometriosis 1Diverticulitis 1Crohn Disease 1Constipation 1Colorectal Neoplasms 1Colonic Diseases 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Bites and Stings 1Bile Duct Neoplasms 1Agnosia 1

Interventions

Nivolumab 142pembrolizumab 129Sunitinib 127Bevacizumab 71Everolimus 70Sorafenib 68cabozantinib 63Ipilimumab 61pazopanib 58Axitinib 57aldesleukin 51Magnetic Resonance Spectroscopy 43Cyclophosphamide 40Interleukin-2 38lenvatinib 36Radiosurgery 36Specimen Handling 33Interferon-alpha 32atezolizumab 28belzutifan 24temsirolimus 23Gemcitabine 23fludarabine phosphate 22Radiotherapy 18Interferon alpha-2 18Biopsy 18fludarabine 17durvalumab 17avelumab 17Paclitaxel 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Renal Cell × Surgical Instruments × Clear all
NCT02075658 2018-02-14

A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation

University of California, Irvine

Phase NA Completed
60 enrolled 9 charts
Genitourinary

Carcinoma, Renal Cell, Pneumoperitoneum

Data powered by HemOnc (CC BY 4.0) Colophon âš¡